Figure 2.
Distribution of scores of the primary outcome (Clinical Global Impression-Improvement scale). The thick black line indicates the cut-off point of improvement (score 1, 2 or 3) vs no change or worsening (score 4, 5, 6 and 7). No significant difference was found between the two treatment arms (BoNT vs placebo; proportional difference of 0.075 (95% CI −0.189 to 0.327; p=0.77)). BoNT, botulinum neurotoxin.